Search clinical trials for: Fenofibrate/fenofibric acid

Total 24286 results

Solvay Pharmaceuticals

Completed

Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO

Dyslipidemia/Glucose Metabolism Disorder

Czech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
The University of Western Australia
National Heart Foundation, Australia

Completed

Pharmacological Regulation of Fat Transport in Metabolic Syndrome

Obesity | Cardiovascular Disease | Hypertriglyceridemia | Lipid Disorders
Abbott

Completed

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

Hyperlipidemia
Solvay Pharmaceuticals

Completed

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

Diabetes Mellitus, Type 2 | Dyslipidemia

France
Veloxis Pharmaceuticals

Completed

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

Dyslipidemia

United States
National Taiwan University Hospital

Available

A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome

Diabetes | CVD
Organon and Co

Completed

Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

Dyslipidemia
Veloxis Pharmaceuticals

Completed

12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

Dyslipidemia

United States
Solvay Pharmaceuticals

Terminated

Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI

Dyslipidemia | Glucose Metabolism Disorder

Poland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Obesity and Nonalcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease

United States
Hoda A. Atta

Completed

Fibrates in Pediatric Cholestasis

Chronic Cholestasis

Egypt
VA Office of Research and Development

Completed

Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

Prediabetic State | Metabolic Syndrome X

United States
Ahmad Slim
GlaxoSmithKline

Terminated

Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL) (RAFAEL)

Hypertriglyceridemia in Type 4 Hyperlipidemia | Non Diabetic Subjects With Normoglycemia

United States
Ospedale di Circolo - Fondazione Macchi
Merck Sharp & Dohme LLC

Unknown

Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

HIV Infections | HIV | Hyperlipidemia

Italy
Aegerion Pharmaceuticals, Inc.

Completed

Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

Healthy

United States
Sanofi

Completed

Insulin Glulisine in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus
Sanofi

Completed

Insulin Glulisine in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Columbia University
University of California, Irvine; Osteoporosis Center of Armenia

Completed

Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate

Osteoporosis, Postmenopausal

Armenia
Novartis

Completed

Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

Dyslipidemia

Germany, Switzerland
Foundation Research, Florida
GlaxoSmithKline; Abbott; Kos Pharmaceuticals

Completed

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

Insulin Resistance | Metabolic Syndrome X

United States
National Taiwan University Hospital

Available

Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia

Hyperlipidemia
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Dyslipidemia

United States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom
Shionogi
Integrium

Completed

A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

Combined Hyperlipidemia

United States
First People's Hospital of Hangzhou

Recruiting

Safety Study of Fenofibrate During Pregnancy

Severe Hypertriglyceridemia During Pregnancy

China
Solvay Pharmaceuticals

Completed

Effects of Fenofibrate on Gene Expression in Healthy Volunteers

Healthy

United Kingdom
Singapore General Hospital
National Medical Research Council (NMRC), Singapore

Unknown

Effects of Fenofibrate Therapy in Diabetic Nephropathy

Diabetes Mellitus | Diabetic Nephropathies

Singapore
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation; Roche Pharma AG; National Eye Institute... and other collaborators

Recruiting

Fenofibrate for Prevention of DR Worsening (Protocol AF)

Diabetic Retinopathy

United States
Mansoura University

Completed

Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants

Neonatal Jaundice
Second Affiliated Hospital of Soochow University

Unknown

Evaluation of Fenofibrate on Radiation-induced Skin Injury

Radiodermatitis

China
Lawson Health Research Institute

Terminated

Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Canada
Seoul National University Bundang Hospital
Daewon Pharmaceutical Co., Ltd.

Recruiting

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Diabetes Mellitus, Type 2 | Atherosclerosis | Dyslipidemia

Korea, Republic of
Medical University of Silesia

Unknown

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines (MSF)

Inflammation | Diabetes | Dyslipidemia | Cytokines

Poland
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

Complex-dyslipidemia
University of California, Irvine

Completed

Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

Huntington Disease

United States
Solvay Pharmaceuticals

Terminated

Effect of Fenofibrate on Sleep Apnea Syndrome

Obesity | Overweight | Dyslipidemia | Sleep Apnea Syndrome

France
Alessandro Doria
University of Michigan; University of Minnesota

Recruiting

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (PERL-FENO)

Diabetic Nephropathies

United States
Indonesia University

Completed

Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume

Diabetes Mellitus | Diabetic Retinopathy | Dyslipidemias
Zydus Lifesciences Limited

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Dyslipidemia | Hypertriglyceridemia

India
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemia
Laboratorios Silanes S.A. de C.V.

Recruiting

Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

Dyslipidemia Associated With Type II Diabetes Mellitus

Mexico
Aegerion Pharmaceuticals, Inc.

Completed

Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

Hyperlipidemia

United States
University of Arkansas
National Institutes of Health (NIH)

Withdrawn

Tissue Lipids and Insulin Resistance

Tissue Lipid Metabolism
University of Pennsylvania

Recruiting

Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate

Covid19

United States
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
VA Office of Research and Development

Completed

Fenofibrate Treatment in SCI

Dyslipidemia | Spinal Cord Injury

United States
Hanlim Pharm. Co., Ltd.

Completed

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

Healthy Male Volunteers

Korea, Republic of
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis

China
Mayo Clinic

Recruiting

A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation (FICsDCD)

Liver Transplant

United States
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
University of Sydney
National Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaborators

Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (FAME 1 EYE)

Diabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes Mellitus

Australia, Hong Kong, New Zealand, United Kingdom

Search clinical trials for: Fenofibrate/fenofibric acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations